Suven Pharmaceuticals has informed that, Kotak Mahindra Capital Company (‘Manager to the Open Offer’) has submitted to BSE a copy of Public Announcement for the attention of the public shareholders of Suven Pharmaceuticals (‘Target Company’) under Regulation 3(1) and Regulation 4 read with Regulations 13, 14 and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto.
The above information is a part of company’s filings submitted to BSE.
